Clinical Nuclear Medicine · 2011 · 25 citations · 2 references
MedicineCardiologyPharmacotherapyCardiac TransplantationCardiothoracic SurgeryPulmonologyAntifungal PharmacologyAntifungal PharmacotherapyAntifungal TherapyFungal InfectionsHeart TransplantationTransplant Infectious ComplicationsAspergillosis TherapyFungal Infections In Transplant RecipientsHeart Transplant CareHeart Transplant RejectionOpportunistic Infection ProphylaxisPulmonary AspergillosisPulmonary Fungal InfectionsThoracic Fungal Infection
A 66-year-old man with a history of heart transplant for idiopathic dilated cardiomyopathy presented with progressive bone pain and myalgias. He has been on voriconazole for a pulmonary Aspergillus infection for 9 months. He had an elevated alkaline phosphatase of 280. There is no history of rheumatologic disease. Drug-induced periostitis has recently been reported in patients on long-term voriconazole therapy after lung transplantation for prophylaxis and treatment of Aspergillus infection. This case demonstrates the same phenomenon in a heart transplant patient. This patient's symptoms improved after discontinuation of voriconazole.
2
Voriconazole Prophylaxis in Lung Transplant Recipients
Shahid Husain, David L. Paterson, Sean Studer et al. · American Journal of Transplantation · 2006 · 215 citations · Full text